In four pre-registered studies across Belgium, the US, and the UK, people judged anti-obesity medication users as putting in less effort and, in turn, viewed them as less moral, competent, warm, and deserving than non-users. The findings suggest that effort moralization may help drive stigma around GLP-1-based weight-loss treatment, even when medication is used alongside diet and exercise.